Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 1
2009 1
2010 3
2011 3
2012 3
2013 3
2014 4
2015 2
2016 5
2017 8
2018 2
2019 6
2020 12
2021 9
2022 9
2023 3
2024 3
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Erratum: Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapy.
Ni W, Garg S, Chowdhury B, Sattler M, Sanchez D, Meng C, Akatsu T, Donovan KA, Qi J, Wang MY, Starnbach CA, Liu X, Guzman MT, Teh WP, Stone R, Griffin JD, Buhrlage S, Weisberg E. Ni W, et al. Among authors: buhrlage s. Mol Ther Oncol. 2025 Mar 28;33(2):200966. doi: 10.1016/j.omton.2025.200966. eCollection 2025 Jun 18. Mol Ther Oncol. 2025. PMID: 40231187 Free PMC article.
Small-molecule allosteric activator of ubiquitin-specific protease 7 (USP7).
Jaen Maisonet I, Sharafi M, Korchak EJ, Salazar-Chaparro A, Bratt A, Parikh T, Varca AC, Shah B, Darnowski M, Chung M, Teh WP, Che J, Bezsonova I, Buhrlage SJ. Jaen Maisonet I, et al. Among authors: buhrlage sj. bioRxiv [Preprint]. 2025 Mar 16:2025.03.14.643379. doi: 10.1101/2025.03.14.643379. bioRxiv. 2025. PMID: 40161813 Free PMC article. Preprint.
Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapy synergy between CARM1 inhibition and IMiDs.
Ni W, Garg S, Chowdhury B, Sattler M, Sanchez D, Meng C, Akatsu T, Donovan KA, Qi J, Wang MY, Starnbach CA, Liu X, Guzman MT, Teh WP, Stone R, Griffin JD, Buhrlage S, Weisberg E. Ni W, et al. Among authors: buhrlage s. Mol Ther Oncol. 2025 Feb 20;33(1):200952. doi: 10.1016/j.omton.2025.200952. eCollection 2025 Mar 20. Mol Ther Oncol. 2025. PMID: 40123976 Free PMC article.
Open-source electrophilic fragment screening platform to identify chemical starting points for UCHL1 covalent inhibitors.
Ficarro SB, Marto ZH, Girardi NM, Deng D, Maisonet IJ, Adelmant G, Fleming LE, Sharafi M, Tavares I, Zhao A, Kim H, Seo HS, Dhe-Paganon S, Buhrlage SJ, Marto JA. Ficarro SB, et al. Among authors: buhrlage sj. SLAS Discov. 2024 Dec;29(8):100198. doi: 10.1016/j.slasd.2024.100198. Epub 2024 Nov 30. SLAS Discov. 2024. PMID: 39622293 Free PMC article.
Proteomic approaches to study ubiquitinomics.
Sahu I, Zhu H, Buhrlage SJ, Marto JA. Sahu I, et al. Among authors: buhrlage sj. Biochim Biophys Acta Gene Regul Mech. 2023 Jun;1866(2):194940. doi: 10.1016/j.bbagrm.2023.194940. Epub 2023 Apr 29. Biochim Biophys Acta Gene Regul Mech. 2023. PMID: 37121501 Free PMC article. Review.
74 results